European Journal of Medicine and Natural Sciences
Volume 4, Issue 2, 2021 · ISSN 2601-6397 (Print) · ISSN 2601-6400 (Online)
The Research of Dynamics of Immune Responsibility Indicators in Patients with Epstein–Barr Virus (EBV) Infections
1V. N. Karazin Kharkiv National University, Ukraine; 2V. N. Karazin Kharkiv National, University, Kharkiv, Ukraine
Submitted: 2021-08-28 · Accepted after Revision: 2021-11-28 · Published: 2021-12-28
Abstract
The main task of modern infectious immunology is the elucidation of immunopathogenetic mechanisms of the unfavourable course of the disease. The course of the infectious process caused by the viruses and the microorganisms factors. At the heart of the complicated flow or chronicity of the process is an ineffective immune response that is not able to prevent the dissemination of the virus or the complete elimination of the pathogen from the body, which is the cause of the formation of relapses or chronic course of the disease. In the modern literature, there is evidence that in patients who have suffered from infectious mononucleosis (IM), regardless of the severity of the disease, a secondary immunodeficiency develops, which is the cause of possible bacterial complications. After IM is not always observed update of the immune balance and changes in the hemogram staying for a long time.
Keywords: research, dynamics, immune, responsibility, indicators, patients, epstein–barr virus, EBV, infections
Introduction
Immunological status of patients with IM has a number of features. The essence of the general pattern of changes is to increase the number of T- and B-lymphocytes at the MI, and in the subpopulation of T-lymphocytes, an increase in the number of cytotoxic cells, which makes it possible to regard the IM as a lymphoproliferative process. Increasing the level of T lymphocytes with suppressor activity is one of the main regulatory mechanisms for suppressing the early stages of B-lymphocyte expression, both directly acting on them and indirectly, inhibiting the activation of T-helper cells. In turn, the reduction of T-helper cells leads to blockage induction of apoptosis. Consequently, with IM there is a slowdown in apoptosis of "exhausted" effector cells and there is no impediment to their participation in the immune response. Ultimately, with EBV infection, the probability of occurrence of auto-reactive, as well as malignant cell clones may appear. A number of researchers note from the side of the humoral link immunity increase the amount of IgA and IgM, which is characteristic of severe forms of MI.
In addition, many researchers are actively studying the relationship between the severity of the course and individual indicators of the immune system. At the primary infection, neutralizing antibodies, antibodies of IgM and IgG antibodies to VCA are formed, and later to EA and NA antigens of EBV. It is believed that the mild IM is associated with an effective immunological defence of the T cell line of immunity and a high level of α-IFN. The severe course of the infection is due to insufficiency of both the cellular and humoral immunity, accompanied by low concentrations of α-IFN, the reversal of IFN products from α to γ-type and violation of the elimination of common CIC.
The number of studies devoted to the study of the nature of immune disorders of laboratory manifestations of IM depending on the stage of the infectious process in adult patients in our country is very limited. It also needs to clarify the diagnostic significance of specific methods of ELISA and PCR in different stages of the infectious process.
The aim of the study. To investigate the nature and extent of immune status disorders in patients with acute EBV infection.
Materials and methods. To accomplish our research objectives, we examined 60 patients with IM.
The diagnosis of IM in patients under our supervision was based on clinical, anamnestic and laboratory data. All patients have undergone a medium-severe form of IM.
The complex of patients' examination included clinical analysis of blood, detection of atypical mononuclear cells, determination of specific Ig to the EBV by solid-phase immunoassay, detection of the DNA of the EBV by polymerase chain reaction (PCR) in blood and saliva in the dynamics of the disease. In order to confirm the diagnosis, in addition to the general analysis of blood, a series of serological and molecular genetic studies were performed. As a screening rapid blood test for the presence of EBV infection, a heterophilic test in the Hoff-Bauer modification was used (Chirekskina, 1973).
The blood lymphocyte phenotype was determined using a flow-through laser cytometry on a FACS-Calibur (USA) apparatus using monoclonal antibodies (Dumbaeva, 2002; Hanunova, 1999). For identification on the cells of CD3 +, CD4 +, CD8 +, CD16 +, СD20 +, СD25 +, СD8 + СD28 +, СD8 + СD28-, appropriate antibodies labelled with FITC were used. The monoclonal antibodies INFγ-RS-5, IL-4-PE, TFRβ-FITC (eVioscience, Beckman) were used to identify the TF lymphocytes INFγ (Th1-cells), IL-4 (Th2-cells) TFRβ1 (Th3-cells) (еВioscience, Beckman Caulter, R&D System). All stages of preparation of samples for laser cytofluorometry were conducted in accordance with the protocols of the manufacturer. The method of simple radial immunodiffusion in a gel was used to study the content of Ig classes A, M, G in serum.
The results of the research were processed by the method of variation and correlation statistics using the program "Statistic 10.0 for Windows". For each variation series, the average arithmetic (M), mean square deviation (σ), average error of the arithmetic mean (m) was calculated. Methods of parametric and nonparametric statistics were also used. Quantitative and qualitative analysis of intra-system and inter-system correlation connections was carried out using the method of correlation structures and the sequential analysis of Wald.
Results of the Research
The complex analysis of the state of the immune response, its nature and intensity, the balance of the subpopulations of the reactive cells, and the production of immunoregulatory molecules is of great importance in the study of pathogenesis and clinics of the EBV infection, which ultimately helps identify the antiviral strategy of the organism.
The subpopulative composition of the main lymphocytes, as well as the indicators reflecting the state of the humoral immune response - the content of CIC and IgA, M, G was studied in the peripheral blood of patients with IM in the dynamics of the disease - in the period of rapid and convalescence (before discharge from the hospital). The results are shown in table 1.
The analysis of the results of the study on the content of relative and absolute indices of the major subpopulations of lymphocytes revealed the heterogeneity of the content of these immunocompetent cells in the period of the onset of the disease. As can be seen from table 1, the subpopulation composition of lymphocytes in the group of patients with IM was characterized by certain qualitative and quantitative differences compared with the control group.
Thus, during the acute period of IM in the peripheral blood of patients due to high content of leucocytes observed significant increase of the relative and absolute number of some subpopulations of lymphocytes compared with the data of the control group patients.
Thus, in patients with IM, the increase in content [CD3+ – 87.21±3.34%; CD4+ – 47.16±1.07%; CD8+ – 44.16±3.78%; CD16+ – 16.61±0.6; CD20+ – 18.91±0.9%; CD8+CD28+ – 17.6±1.1%; CD25+ – 21.4±1.92%], (p<0.05) compared with similar parameters of the control group [CD3+ – 65.85±3.5%; CD4+ – 42.0±1.31%; CD8+ – 29.4±1.9%; CD16+ – 14.52±0.44%; CD20+ – 13.5±0.5%; CD8+CD28+ – 14.8±0.9%; CD25+ – 16.0±1.45%] (p<0.05) was exceeded. The increase in Th1-cell content was also observed in probability and was 15.2±0.94% versus 11.1±1.1% (p<0.05). The values below the control values were CD8+CD28-, which did not differ from the control values – 5.7±0.3% (p>0.05), and the Th2-cell content tended to decrease: 10.4±1,78 versus 12.4±1.43 (p>0.05), respectively.
Thus, the study of the phenotypic spectrum of lymphocytes showed an increase in the content of mature T-lymphocytes (CD3+), cytotoxic T-suppressor cells (CD8+), cells expressing the activation marker CD25+ (receptor IL-2). The imbalance in the ratio Th1/Th2 (p<0.001), due to an increase in the relative content of Th1-cell Th-lymphocytes, confirms that the effective protection and elimination of the pathogen is formed by transforming the T-helper response toward Th1 cells. In addition, an increase in the number of lymphocytes that carry the receptor to IL-2 (CD25+) in the acute period is evidently indicative of activation of the immune system and an increase in the number of cells that respond to IL-2.
In the period of convalescence, a probable reduction was observed only with respect to the relative content of lymphocytes from 57.67±2.81 to 45.65±2.32% and 5.74±0.65 to 3.6±0.38 x 109 (p<0,05), the index of CD3+ was 87.21±3.34 to 79.21±2.29% (p<0.05).
Table 1. Subpopulation of lymphocytes of peripheral blood of patients with MI (M ± m)
| Indicator | IM, the acute period (n=60) |
IM, the period of convalescence (n=60) | Control (n=20) |
| Leukocytes, (109/л) | 12,7±0,8 1,2 | 6,77±0,36 | 5,37±0,18 |
| Lymphocytes, (%) | 57,67±2,81 1,2 | 45,65±2,32 1 | 30,1±1,75 |
| Lymphocytes, (109/л) | 5,74±0,65 1,2 | 3,6±0,38 1 | 2,55±0,18 |
| CD3+-cells, % | 87,21±3,34 1,2 | 79,21±2,29 1 | 65,85±3,5 |
| CD4+ -cells, % | 47,16±1,07 1 | 44,6±0,98 | 42,0±1,31 |
| CD8+-cells, % | 44,16±3,78 1 | 36,6±2,7 1 | 29,4±1,9 |
| CD16+-cells, % | 16,61±0,6 1 | 14,8±0,46 | 14,52±0,44 |
| CD20+-cells, % | 18,91±0,9 1 | 16,11±0,6 1 | 13,5±0,5 |
| CD8+CD28+-cells, % | 17,6±1,1 1 | 15,5±0,9 | 14,8±0,6 |
| CD8+CD28–-cells, % | 5,7±0,3 | 5,3±0,27 | 5,1±0,3 |
| CD8+CD28+/CD8+CD28– | 3,08±0,3 | 2,9±0,3 | 2,9±0,4 |
| СD25+-cells, % | 21,40±0,92 1 | 19,41±0,86 1 | 16,0±0,65 |
| Th1 (INFγ), % | 15,2±0,94 1 | 13,7±0,98 | 11,1±1,1 |
| Th2 (IL-4+), % | 10,4±1,78 | 11,3±1,67 | 12,4±1,43 |
| Th1/Th2 | 1,46±0,06 1 | 1,21±0,07 | 0,89±0,09 |
Notes: 1 is a probable difference with the control group (p <0.05), 2 is the probable difference with the parameters of the convalescence period (p <0.05).
Other clusters of lymphocytes tended to decrease the content compared to those at the acute period of the IM (p>0.05) and did not differ with probability compared with the data of the convalescence period (p>0.05). It should be noted that in this period, the probable differences with the control data had a relative content of lymphocytes of 45.65±2.32 versus 30.1±1.75% and 3.6±0.38 versus 2.55±0.18 x 109 (p<0.05); CD3+ levels were 79.21±2.29 versus 65.85±3.5% (p<0.05); CD8+ – 36.6±2.7 versus 29.4±1.9% (p<0.05); СD20+ – 16.11±0.6 versus 13.5±0.5% (p<0.05) and СD25+ – 19.41±0.86 versus 16.0±0.65% (p<0.05).
It should be noted that in this period the distribution of the content of the indicators according to the control data was characterized by diversification, which in our opinion confirms a rather slow regression of clinical symptoms in the MI and the existence of an imbalance in both the acute period and the period of convalescence.
Conclusions
- In patients with IM in the period of the acute period of the disease, probable violations from the cellular immunity level, characterized by an increase in the number of cells with killer activity: mature T-lymphocytes (CD3+), cytotoxic T-suppressor cells (CD8+), cells expressing activation marker CD25+ (receptor IL-2) and a sharp drop in Th1/Th2.
- In the period of convalescence of the IM in a greater number of patients, the prevalence of the Th2-type immune response was detected, indicating a prolonged period of convalescence and predisposition to chronic disease.
References
Cen О, Longnecker R. Latent Membrane Protein 2 (LMP2). Curr Top Microbiol Immunol. 2015; 391: 151–80. DOI: 10.1007/978-3-319-22834-1_5
Drutskaya MS, Belousov PV, Nedospasov SA. Vrozhdennoye raspoznavaniye virusov. Molekulyarnaya biologiya. 2011; 45 (1): 7–19. [Russian].
Griffin BD, Gram AM, Mulder A, Van Leeuwen D, Claas FH, Wang F, Ressing ME, Wiertz E. EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail. J Immunology. 2013; 190: 1672–84. DOI: 10.4049/jimmunol.1102462
Fathallah I, Parroche P, Gruffat H, Zannetti C, Johansson H, Yue J, Manet E, Tommasino M, Sylla BS, Hasan UA. EBV latent membrane protein 1 is a negative regulator of TLR9. J Immunology. 2010; 185: 6439–47. DOI: 10.4049/jimmunol.0903459
Gaudreault E, Fiola S, Olivier M, Gosselin J. Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J Virology. 2007; 81: 8016–24. DOI: 10.1128/JVI.00403-07
Fish K, Chen J, Longnecker R. Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma. Blood. 2014; 123: 530–40. doi: 10.1182/blood-2013-07-517649
Fukuda M, Kawaguchi Y. Role of the immunoreceptor tyrosine-based activation motif of latent membrane protein 2A (LMP2A) in Epstein-Barr virus LMP2A-induced cell transformation. J Virology. 2014; 88: 5189–94. doi: 10.1128/JVI.03714-13
Gibson J, Gow N, Wong SY. Expression and Funktion of innate Pattent Recognition Receptors in T and B cells. Immun, Endoc&Metab Agents in Med Chem. 2010; 10: 11-20.
Guerreiro M, Na IK, Letsch A, Haase D, Bauer S, Meisel C, Roemhild A, Reinke P, Volk HD, Scheibenbogen C. Human peripheral blood and bone marrow EBV-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets. Eur J Immune. 2010; 15: 1566-76. DOI: 10.1002/eji.200940000
Isakov VA, Arkhipova EI, Isakov DV. Gerpesvirusnyye infektsii cheloveka: rukovodstvo dlya vrachey. SPb, 2006. 303 s. [Russian].
Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010; 11 (5): 373–84. DOI: 10.1038/ni.1863
Krasnitskaya AS, Borovskaya NA. Immunologicheskiye aspekty khronicheskogo tonzillita, assotsiirovannogo s virus Epshteyna-Barr infektsiyey. Fundamentalnyye issledovaniya. 2012; 299–305. [Russian].
Kudin AP. Eta «bezobidnaya» virus Epshtejna – Barr infekciya. Chast 1. Harakteristika vozbuditelya. Reakciya immunnoj sistemy na virus. Medicinskie novosti. 2006; 7: 25-32. [Russian].
Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M. The pathogenesis of Epstein-Barr virus persistent infection. Curr Opin Virol. 2013. 3: 227–32. DOI: 10.1016/j.coviro.2013.04.005
Tugizov S, Herrera R, Veluppillai P, Greenspan J, Greenspan D, Palefsky JM. Epstein-Barr Virus (EBV)-Infected Monocytes Facilitate Dissemination of EBV within the Oral Mucosal Epithelium. J Virol. 2007; 81 (11): 5484-96. doi: 10.1128/JVI.00171-07
Vozianova ZH, Hley AI. I. Infektsiyniy mononukleoz yak polietiolohichne zakhvoryuvannya. Suchasni infektsiyi. 2004; 2: 37-41. [Ukrainian].
© 2021 The Author(s). Published by Mentisia under CC BY-SA 4.0.